Novartis Corporate Governance

Novartis Investor Relations

Corporate governance

Novartis is fully committed to good corporate governance. The Group’s principles and rules on corporate governance are laid down in the Articles of Incorporation, the Regulations of the Board and the Charters of the Board Committees.

The Board’s Corporate Governance Committee reviews these principles and rules regularly in light of prevailing best practices and forwards suggestions for improvement to the full Board for approval.

On request, Novartis will provide shareholders with a printed copy of our Annual Report or 20-F free of charge. These documents contain our complete audited financial statements. Please use the following order form to complete your request.

Download the Annual Report 2009
Corporate Governance Section page 97

Good corporate governance may return goodwill in aftermath of financial crisis

Articles of Incorporation

English
(680 KB)

German
(725 KB)

French
(625 KB)

Regulations of the Board (full version including both the regulations and all committee charters)	English (121 KB)
Chairman's Committee Charter	English (21 KB)
Compensation Committee Charter	English (22 KB)
Audit and Compliance Committee Charter	English (35 KB)
Corporate Governance and Nomination Committee Charter	English (27 KB)
Risk Committee Charter	English (19 KB)
Appendix: Independence Criteria for the Board of Directors and its Committees	English (49 KB)
Hiring Restrictions for Auditors	English (52 KB)
Audit and Compliance Committee Pre-Approval Policy	English (63 KB)
Pre-approval Framework: Audit Services	English (54 KB)
Novartis Code of Ethical Conduct for CEO and Senior Financial Officers	English (60 KB)